Brief: Biosergen Q4 EPS at SEK -0.13
29/02/2024 07:50
Feb 29 (Reuters) - Biosergen Q4 EPS SEK -0.13. * Q4 EBITDA SEK -6.662 thousand * Q4 net income SEK -6.469 thousand
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million